Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Global indices provide a universal yardstick for international portfolios. Compare regional performance and refine allocations with credible benchmarks.
15,316 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A late 2025 study finds workers would sacrifice up to a quarter of compensation to keep remote work options. The resu...
A surprise accounting disclosure sent Driven Brands shares skidding. This guide breaks down what happened, how to ass...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
A lone developer demonstrates embedding an image in a single Bitcoin transaction, igniting a debate over BIP-110 data...
In a market where homes linger and prices shift, using lowball offers can put you in the driver's seat. Learn how to ...
Awards season is about glamour, opinions, and yes, money. This guide breaks down the costs behind the red carpet, how...
As AI reshapes design tools, a Claude-powered tie-up could shift Figma's growth trajectory. This article breaks down ...
Leveraged ETFs promise outsized gains, but they are built for daily moves, not long-term investing. This guide breaks...
SoundHound AI is delivering impressive revenue momentum, but its stock has tumbled. This analysis breaks down the dri...
Nokomis Capital quietly builds a new position in Apple Hospitality REIT, underscoring a rising appetite for hospitali...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...